SGT-151 Buy

SGT-151 Buy Novel psychoactive compounds, known as synthetic cannabinoids (SCs), mimic the effects of cannabis. These goods, which included herbal mixtures laced with SCs, were offered for sale on internet retailers. Due to their synthesis in clandestine laboratories, often based on pharmaceutical research and patents, a flood of chemical variations of SCs has since emerged worldwide, causing increasing difficulties for authorities in regulating these compounds. In recent years, a number of highly potent compounds synthesized according to Bowden and Williamson's patent application ("SCT compounds") have become available for purchase. These drugs are characterized by a cumyl substituent attached to an indole, indazole or azaindole structure. In 2016, it was discovered that CUMYL-PEGACLONE, one of the first coumyl compounds, was being marketed under the brand. ]. The present study aims to understand what is inside an SGT-151 package sold on the internet as a "research chemical".

With the help of the Cayman database, the cannabinoid was identified using its mass spectra (Chemical C. Cayman Spectral Library, Vol. v08302018). The substance was analyzed by GC/MS using a MEGA-5 MS capillary column (0.25 µm, 0.32 mm, 30 m). The following parameters were used for the chromatographic analysis: Splitless injection at 280 °C and an injection volume of 1 µL. After the temperature had been at 100 °C for three minutes, the oven was ramped up to 310 °C at a rate of 30 °C per minute and held at this temperature for ten minutes. The following MS conditions were: The ionization energy was set to 70 eV and the scan mode range used for acquisition was 30 to 450. The carrier gas in this case was helium. Clarity used an HPLC/DAD for purification. program in conjunction with a phase reversal column. A solvent gradient system with (A) 5 % 10 mM ammonia format and (B) 95 % acetonitrile, optimized for optimal resolution, formed the mobile phase.